Anne Luong

This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Akebia Therapeutics, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Luong. Retrieved from https://idiyas.com/inventor/anne-luong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 73(Granted Patents)

Company Filing History:

8 out of 38

Akebia Therapeutics, Inc.

patents

Years Active: 2017-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12419877 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2025-09-23),

2. 11690836 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2023-07-04),

3. 11065237 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2021-07-20),

4. 10596158 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2020-03-24),

5. 10150734 - Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof (2018-12-11),

6. 10149842 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2018-12-11),

7. 9987262 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2018-06-05),

8. 9701636 - Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof (2017-07-11),

Title: The Innovative Contributions of Anne Luong

Introduction

Anne Luong is a prominent inventor based in Mississauga, Canada. She has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. Her work focuses on developing solid forms of compounds that have potential therapeutic applications.

Latest Patents

Among her latest patents is the development of solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid. This patent includes compositions and methods for making these solid forms, as well as their uses in treating various diseases and disorders. The innovative nature of her work lies in the potential applications of these compounds in medical treatments.

Career Highlights

Anne Luong has worked with notable companies in the pharmaceutical industry, including Akebia Therapeutics, Inc. and Gilead Sciences, Inc. Her experience in these organizations has allowed her to contribute to significant advancements in drug development and formulation.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues such as James Densmore Copp and Ann W Newman. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Anne Luong's contributions to the pharmaceutical industry through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.